Abstract
Human papillomavirus (HPV) vaccination rates remain suboptimal among African American adolescents. Although provider recommendations during clinical encounters are believed to be highly effective in increasing uptake and series completion, little has been reported about parent–child perspectives on the counseling received during these encounters. Among African American parent–child dyads, we sought to explore and compare interactions, needs, and preferences during clinical encounters by child’s HPV vaccination status. We applied a qualitative, phenomenological study design to conduct semi-structured interviews with African American parent–child dyads representing children who were unvaccinated (n = 10), had initiated but not completed (n = 11), or had completed the HPV vaccine series (n = 9). Using iterative, inductive-deductive thematic analysis, five themes were generated: (1) parents’ attitudes varied about the HPV vaccine but were mostly positive for vaccines in general; (2) patient-parent-provider clinical encounters from the parent perspective; (3) patient-parent-provider clinical encounters from the child perspective; (4) methods of distribution of supplemental HPV information; and (5) communication desired on HPV vaccination by parents and children. Parents stating they received a provider’s recommendation increased by vaccination status (unvaccinated: 6 out of 10; initiated: 7 out of 11; completed: 9 out of 9). Most parents and children were not satisfied with provider communication on the HPV vaccine and used supplemental materials to inform decision-making. Ongoing communication on the HPV vaccine was requested even post-vaccination of the child. During clinical encounters, children and parental messaging needs are similar yet dissimilar. We offer communication strategies and messaging that can be used for African American parent–child dyads by child HPV vaccination status during a clinical encounter.
Similar content being viewed by others
Data Availability
Due to the confidentiality agreements, supporting data cannot be made openly available.
Change history
30 October 2023
A Correction to this paper has been published: https://doi.org/10.1007/s40615-023-01845-6
References
Centers for Disease Control and Prevention. Vaccines at 11 to 12 Years. Secondary Vaccines at 11 to 12 Years 2022. http://www.cdc.gov/vaccines/parents/by-age/years-11-12.html. Accessed 11 June 2023.
National HPV Roundtable. HPV Vaccination at 9–12 Years of Age. Secondary HPV Vaccination at 9–12 Years of Age 2022. https://hpvroundtable.org/wp-content/uploads/2022/04/Evidence-Summary-HPV-Vaccination-Age-9-12-Final.pdf. Accessed 9 June 2023.
American Academiy of Pediatrics. Human papillomavirus and other vaccines recommended for adolescents. Secondary Human Papillomavirus and Other Vaccines Recommended for Adolescents 2022. https://www.aap.org/en/patient-care/immunizations/human-papillomavirus-and-other-vaccines-recommended-for-adolescents/#:~:text=The%20AAP%20recommends%20routine%20HPV,completion%20of%20the%20vaccination%20series. Accessed 11 June 2023.
Pingali C, Yankey D, Elam-Evans LD, et al. National vaccination coverage among adolescents aged 13–17 years - National Immunization Survey-Teen, United States, 2021. MMWR Morb Mortal Wkly Rep. 2022;71(35):1101–8. https://doi.org/10.15585/mmwr.mm7135a1.
Mansfield LN, Silva SG, Merwin EI, Chung RJ, Gonzalez-Guarda RM. Factors associated with human papillomavirus vaccine series completion among adolescents. Am J Prev Med. 2021;61(5):701–8. https://doi.org/10.1016/j.amepre.2021.04.031|.
Chou B, Krill LS, Horton BB, Barat CE, Trimble CL. Disparities in human papillomavirus vaccine completion among vaccine initiators. Obstet Gynecol. 2011;118(1):14–20. https://doi.org/10.1097/AOG.0b013e318220ebf3.
Gallagher KE, Kadokura E, Eckert LO, et al. Factors influencing completion of multi-dose vaccine schedules in adolescents: a systematic review. BMC Public Health. 2016;16:172. https://doi.org/10.1186/s12889-016-2845-z.
Spencer JC, Calo WA, Brewer NT. Disparities and reverse disparities in HPV vaccination: a systematic review and meta-analysis. Prev Med. 2019;123:197–203. https://doi.org/10.1016/j.ypmed.2019.03.037.
Fisher H, Trotter CL, Audrey S, MacDonald-Wallis K, Hickman M. Inequalities in the uptake of human papillomavirus vaccination: a systematic review and meta-analysis. Int J Epidemiol. 2013;42(3):896–908. https://doi.org/10.1093/ije/dyt049.
Beavis AL, Gravitt PE, Rositch AF. Hysterectomy-corrected cervical cancer mortality rates reveal a larger racial disparity in the United States. Cancer. 2017;123(6):1044–50. https://doi.org/10.1002/cncr.30507.
Liao CI, Francoeur AA, Kapp DS, Caesar MAP, Huh WK, Chan JK. Trends in human papillomavirus-associated cancers, demographic characteristics, and vaccinations in the US, 2001–2017. JAMA Netw Open. 2022;5(3):e222530. https://doi.org/10.1001/jamanetworkopen.2022.2530.
Osazuwa-Peters N, Simpson MC, Rohde RL, Challapalli SD, Massa ST, AdjeiBoakye E. Differences in sociodemographic correlates of human papillomavirus-associated cancer survival in the United States. Cancer Control. 2021;28:10732748211041894. https://doi.org/10.1177/10732748211041894.
Galbraith KV, Lechuga J, Jenerette CM, Moore LA, Palmer MH, Hamilton JB. Parental acceptance and uptake of the HPV vaccine among African-Americans and Latinos in the United States: a literature review. Soc Sci Med. 2016;159:116–26. https://doi.org/10.1016/j.socscimed.2016.04.028.
Johnson KL, Lin MY, Cabral H, Kazis LE, Katz IT. Variation in human papillomavirus vaccine uptake and acceptability between female and male adolescents and their caregivers. J Community Health. 2017;42(3):522–32. https://doi.org/10.1007/s10900-016-0284-5|.
Amboree TL, Sonawane K, Deshmukh AA, Montealegre JR. Regular healthcare provider status does not moderate racial/ethnic differences in human papillomavirus (HPV) and HPV vaccine knowledge. Vaccines (Basel). 2021;9(7):802. https://doi.org/10.3390/vaccines9070802.
Galbraith-Gyan KV, Lechuga J, Jenerette CM, Palmer MH, Moore AD, Hamilton JB. HPV vaccine acceptance among African-American mothers and their daughters: an inquiry grounded in culture. Ethn Health. 2019;24(3):323–40. https://doi.org/10.1080/13557858.2017.1332758.
Greenfield LS, Page LC, Kay M, Li-Vollmer M, Breuner CC, Duchin JS. Strategies for increasing adolescent immunizations in diverse ethnic communities. J Adolesc Health. 2015;56(5 Suppl):S47-53. https://doi.org/10.1016/j.jadohealth.2014.10.274.
Lau M, Lin H, Flores G. Factors associated with human papillomavirus vaccine-series initiation and healthcare provider recommendation in US adolescent females: 2007 National Survey of Children’s Health. Vaccine. 2012;30(20):3112–8. https://doi.org/10.1016/j.vaccine.2012.02.034|.
Washington A, Chabaan J, Fakih A, et al. “Should I Give it to My Kids?”: factors that influence HPV vaccine hesitancy among African American Parents. Cancer Epidemiol Biomarkers Prev. 2022;31(7):1512. https://doi.org/10.1158/1055-9965.Epi-22-0478.
Kornides ML, McRee AL, Gilkey MB. Parents Who decline HPV vaccination: who later accepts and why? Acad Pediatr. 2018;18(2s):S37-s43. https://doi.org/10.1016/j.acap.2017.06.008.
Henderson RL, Zoucha R, Colbert A, Braxter BJ. Exploring cultural factors of human papillomavirus vaccination acceptance in African Americans: an integrative review. J Transcult Nurs. 2022;33(6):723–31. https://doi.org/10.1177/10436596221125899.
Cunningham-Erves J, Forbes L, Ivankova N, Mayo-Gamble T, Kelly-Taylor K, Deakings J. Black mother’s intention to vaccinate daughters against HPV: a mixed methods approach to identify opportunities for targeted communication. Gynecol Oncol. 2018;149(3):506–12. https://doi.org/10.1016/j.ygyno.2018.03.047.
Fu LY, Zimet GD, Latkin CA, Joseph JG. Associations of trust and healthcare provider advice with HPV vaccine acceptance among African American parents. Vaccine. 2017;35(5):802–7. https://doi.org/10.1016/j.vaccine.2016.12.045.
Leask J, Kinnersley P. Physician communication with vaccine-hesitant parents: the start, not the end, of the story. Pediatrics. 2015;136(1):180–2. https://doi.org/10.1542/peds.2015-1382.
Niccolai LM, Hansen CE, Credle M, Shapiro ED. Parents’ recall and reflections on experiences related to HPV vaccination for their children. Qual Health Res. 2016;26(6):842–50. https://doi.org/10.1177/1049732315575712.
Fenton A, Eun TJ, Clark JA, Perkins RB. Calling the shots? Adolescents’ influence on human papillomavirus vaccine decision-making during clinical encounters. J Adolesc Health. 2020;66(4):447–54. https://doi.org/10.1016/j.jadohealth.2019.10.020.
Alexander AB, Stupiansky NW, Ott MA, Herbenick D, Reece M, Zimet GD. Parent-son decision-making about human papillomavirus vaccination: a qualitative analysis. BMC Pediatr. 2012;12(1):192. https://doi.org/10.1186/1471-2431-12-192.
Gamble HL, Klosky JL, Parra GR, Randolph ME. Factors influencing familial decision-making regarding human papillomavirus vaccination. J Pediatr Psychol. 2010;35(7):704–15. https://doi.org/10.1093/jpepsy/jsp108.
Mathur MB, Mathur VS, Reichling DB. Participation in the decision to become vaccinated against human papillomavirus by California high school girls and the predictors of vaccine status. J Pediatr Health Care. 2010;24(1):14–24. https://doi.org/10.1016/j.pedhc.2008.11.004.
Sisson H, Wilkinson Y. An integrative review of the influences on decision-making of young people about human papillomavirus vaccine. J Sch Nurs. 2018;35(1):39–50. https://doi.org/10.1177/1059840518805816.
Agrawal S, Morain SR. Who calls the shots? The ethics of adolescentself-consent for HPV vaccination. J Med Ethics. 2018;44(8):531–5. https://doi.org/10.1136/medethics-2017-104694.
Matua GA, Van Der Wal DM. Differentiating between descriptive and interpretive phenomenological research approaches. Nurse Res. 2015;22(6):22–7. https://doi.org/10.7748/nr.22.6.22.e1344.
Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–57. https://doi.org/10.1093/intqhc/mzm042.
Rosenstock I. The health belief model and preventive health behavior. Health Educ Monogr. 1974;2(4):354–86.
Guest G, Bunce A, Johnson L. How many interviews are enough?: An experiment with data saturation and variability. Field Methods. 2006;18(1):59–82. https://doi.org/10.1177/1525822X05279903.
Morse JM. Designing funded qualitative research. Thousand Oaks, CA: Sage Publications; 1994.
Creswell J. Qualitative inquiry and research design: choosing among five traditions. California, United States of America: SAGE Publications Inc.; 1998.
Connors E, Selove R, Canedo J, et al. Improving community advisory board engagement in precision medicine research to reduce health disparities. J Health Dispar Res Pract. 2019;12(6):80–94.
Cervcal Cancer Free Tennessee Coalition. The cervical cancer elimination Tennessee initiative. Secondary the cervical cancer elimination Tennessee initiative; 2022. www.cervicalcancerfreecoalition.org/. Accessed 9 June 2023.
Giorgia A. The theory, practice, and evaluation of the phenomenological method as a qualitative research procedure. J Phenomenol Psychol. 1997;28:235–60.
Englander M. The interview: data collection in descriptive phenomenological human scientific research. J Phenomenol Psychol. 2012;43:13–25.
Giorgi A. The descriptive phenomenological method in psychology - a modified husserlian approach. Pittsburgh: Duquesne University Press; 2009.
Lee PA, Greenfield G, Pappas Y. Patients’ perception of using telehealth for type 2 diabetes management: a phenomenological study. BMC Health Serv Res. 2018;18(1):1–9. https://doi.org/10.1186/s12913-018-3353-x.
Oh NL, Biddell CB, Rhodes BE, Brewer NT. Provider communication and HPV vaccine uptake: a meta-analysis and systematic review. Prev Med. 2021;148:106554. https://doi.org/10.1016/j.ypmed.2021.106554.
Bernstein TA, Broome M, Millman J, Epstein J, Derouin A. promoting strategies to increase HPV vaccination in the pediatric primary care setting. J Pediatr Health Care. 2022;36(2):e36–41. https://doi.org/10.1016/j.pedhc.2021.10.009.
Gilkey MB, McRee AL. Provider communication about HPV vaccination: a systematic review. Hum Vaccin Immunother. 2016;12(6):1454–68. https://doi.org/10.1080/21645515.2015.1129090.
Francis JKR, Rodriguez SA, Dorsey O, et al. Provider perspectives on communication and dismissal policies with HPV vaccine hesitant parents. Prev Med Rep. 2021;24:101562. https://doi.org/10.1016/j.pmedr.2021.101562.
Dempsey AF, Pyrzanowski J, Lockhart S, Campagna E, Barnard J, O’Leary ST. Parents’ perceptions of provider communication regarding adolescent vaccines. Hum Vaccin Immunother. 2016;12(6):1469–75. https://doi.org/10.1080/21645515.2016.1147636.
Imanishi Y, Kinoshita T, Sakamoto M, et al. Importance of human papillomavirus vaccination leaflets focusing on the safety profile targeted pediatricians in Japan. Vaccine. 2022;40(34):5010–5. https://doi.org/10.1016/j.vaccine.2022.07.008[published.
Cartmell KB, Mzik CR, Sundstrom BL, Luque JS, White A, Young-Pierce J. HPV vaccination communication messages, messengers, and messaging strategies. J Cancer Educ. 2019;34(5):1014–23. https://doi.org/10.1007/s13187-018-1405-x.
Shah PD, Calo WA, Gilkey MB, et al. Questions and concerns about HPV vaccine: a communication experiment. Pediatrics. 2019;143(2):e20181872. https://doi.org/10.1542/peds.2018-1872.
Malo TL, Gilkey MB, Hall ME, Shah PD, Brewer NT. Messages to motivate human papillomavirus vaccination: national studies of parents and physicians. Cancer Epidemiol Biomarkers Prev. 2016;25(10):1383–91. https://doi.org/10.1158/1055-9965.Epi-16-0224.
Cunningham-Erves J, Hull PC, Wilkins CH, Edwards KM, Davis M, Jones J, Graham J, Adekunle A, Dempsey AF. Healthcare providers' practice protocols, strategies, and needed tools to address parental HPV vaccine hesitancy: an exploratory study. Hum Vaccin Immunother. 2022;18(6):2136862. https://doi.org/10.1080/21645515.2022.2136862.
Clinical and Translational Science Awards Consortium Community Engagement Key Function Committee Task Force on the Principles of Community Engagement. Principles of Community Engagement. 2nd ed. Washington, DC: U.S. Department of Health and Human Services, 2011. https://www.atsdr.cdc.gov/communityengagement/pdf/PCE_Report_508_FINAL.pdf. Accessed 9 June 2023.
Krist AH, Tong ST, Aycock RA, Longo DR. Engaging patients in decision-making and behavior change to promote prevention. Stud Health Technol Inform. 2017;240:284–302.
Kreuter MW, Lukwago SN, Bucholtz RD, Clark EM, Sanders-Thompson V. Achieving cultural appropriateness in health promotion programs: targeted and tailored approaches. Health Educ Behav. 2003;30(2):133–46. https://doi.org/10.1177/1090198102251021.
Acknowledgements
The authors would like to acknowledge members of the Meharry-Vanderbilt-Tennessee State University Cancer Partnership Community Advisory Board (CAB) for being actively engaged throughout this research process. Their input was essential for the success of this project. The authors would also like to thank the African American parents and children for their valuable insights on communication needs for the HPV vaccine.
Funding
This work was supported by the Vanderbilt Patient Centered Outcomes Research Career Knowledge, Education, and Training (K12) Program by a grant from the Agency for Healthcare Research and Quality under grant number 5K12HS022990-05, National Cancer Institute under grant numbers K01CA237748 and U54CA163072.
Author information
Authors and Affiliations
Contributions
Jennifer Cunningham-Erves, Amanda Dempsey, Pamela Hull, and Consuelo H Wilkins were responsible for conceptualization, methodology, validation, resources, and funding acquisition. Jennifer Cunningham-Erves, Meredith Smalls, and Elizabeth Stewart were responsible data curation and writing—original draft. Jennifer Cunningham-Erves were responsible for data collection and management and survey data analysis. Kathryn Edwards assisted in data interpretation. The first draft of the manuscript was written by Jennifer Cunningham-Erves and all authors were responsible for the review and editing of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics Approval
This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Meharry Medical College Institutional Review Board (Date: 7.30.2020; Protocol Number: 16–06-569).
Consent to Participate
Informed consent was obtained parents and assent from children after being explained the study procedures including purpose, risks, and benefits.
Consent for Publication
The authors affirm that human research participants provided informed consent for publication of aggregate data.
Competing Interests
KME: Consultant to Bionet and IBM: Member Data Safety and Monitoring Board for Sanofi, X-4 Pharma, Seqirus, Moderna, Pfizer, Merck, and Roche. JCE: Education Consultant and Advisory Board Member for MERCK. All other authors declare no conflicts of interest.
Disclaimer
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original version of this article was revised: The abstract has been updated to accurately report data concerning numbers of study participants.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Cunningham-Erves, J., Smalls, M., Stewart, E.C. et al. Communication Interactions, Needs, and Preferences During Clinical Encounters of African American Parent–Child Dyads. J. Racial and Ethnic Health Disparities (2023). https://doi.org/10.1007/s40615-023-01754-8
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s40615-023-01754-8